Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-02-25 @ 3:35 AM
Study NCT ID:
NCT00109005
Status:
COMPLETED
Last Update Posted:
2017-01-02
First Post:
2005-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
050095
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None